Jim Palma

Jim Palma is Chief Executive Officer of TargetCancer Foundation. Since joining TargetCancer Foundation (TCF) in 2010, Jim has overseen its growth from a small, Boston-based start-up to a nationally recognized foundation driving comprehensive rare cancer research programs and patient support services.

Jim is a founding Co-Chair of the National Organization for Rare Disorders (NORD) Rare Cancer Coalition, and also served for 9 years as a member of the NORD Board of Directors. In addition, Jim serves as Co-Chair of the WIN Consortium in Cancer Personalized Medicine Rare Cancers Committee, as a member of the Advisory Board of the Transformative Rare Cancer Initiative (TRACER) at the Fred Hutchinson Cancer Center, and as a member of the Programmatic Panel of the Rare Cancers Program at the Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Prior to joining TargetCancer Foundation, Jim spent eleven years at Fidelity Investments in Boston, MA. Jim completed studies at the Institute for Nonprofit Management and Leadership at the Questrom School of Business at Boston University, and received his B.A. from Loyola University Maryland.